Cargando…

Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions

BACKGROUND: Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography. METHODS: A total of 128 CTO patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Aktürk, Erdal, Aşkın, Lütfü, Taşolar, Hakan, Kurtoğlu, Ertuğrul, Türkmen, Serdar, Tanrıverdi, Okan, Uzel, Kader Eliz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Akadémiai Kiadó 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044539/
https://www.ncbi.nlm.nih.gov/pubmed/32148912
http://dx.doi.org/10.1556/1646.11.2019.15
_version_ 1783501593571753984
author Aktürk, Erdal
Aşkın, Lütfü
Taşolar, Hakan
Kurtoğlu, Ertuğrul
Türkmen, Serdar
Tanrıverdi, Okan
Uzel, Kader Eliz
author_facet Aktürk, Erdal
Aşkın, Lütfü
Taşolar, Hakan
Kurtoğlu, Ertuğrul
Türkmen, Serdar
Tanrıverdi, Okan
Uzel, Kader Eliz
author_sort Aktürk, Erdal
collection PubMed
description BACKGROUND: Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography. METHODS: A total of 128 CTO patients were included. Mehran score, lesion characteristics, interventional procedure, serological specimens and devices were recorded. The first group was administered with 1 ml · kg(−1) · h(−1) saline (0.9% NaCl) infusion that started 12 h before the procedure and continued 12 h post procedure as recommended by the guidelines. The second group was administered with saline infusion of 12 ml · kg(−1) · h(−1) only during CTO-PCI procedure, which is called as intensive infusion. RESULTS: CIN development was similar in two groups (four patients in standard hydration group and five patients in intensive hydration group). The amount of saline was significantly higher in the standard group (1,767 ± 192.2 vs. 1,043.6 ± 375; p < 0.001). Patients with higher creatinine levels prior to PCI had a higher rate of CIN development after procedure. Interestingly, age, left ventricular ejection fraction, and diabetes mellitus independently predicted CIN. CONCLUSION: Intensive hydration administration appears to be an effective and cost-effective method in CTO-PCI patients, especially in patients without left ventricular function failure.
format Online
Article
Text
id pubmed-7044539
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Akadémiai Kiadó
record_format MEDLINE/PubMed
spelling pubmed-70445392020-03-06 Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions Aktürk, Erdal Aşkın, Lütfü Taşolar, Hakan Kurtoğlu, Ertuğrul Türkmen, Serdar Tanrıverdi, Okan Uzel, Kader Eliz Interv Med Appl Sci Original Paper BACKGROUND: Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography. METHODS: A total of 128 CTO patients were included. Mehran score, lesion characteristics, interventional procedure, serological specimens and devices were recorded. The first group was administered with 1 ml · kg(−1) · h(−1) saline (0.9% NaCl) infusion that started 12 h before the procedure and continued 12 h post procedure as recommended by the guidelines. The second group was administered with saline infusion of 12 ml · kg(−1) · h(−1) only during CTO-PCI procedure, which is called as intensive infusion. RESULTS: CIN development was similar in two groups (four patients in standard hydration group and five patients in intensive hydration group). The amount of saline was significantly higher in the standard group (1,767 ± 192.2 vs. 1,043.6 ± 375; p < 0.001). Patients with higher creatinine levels prior to PCI had a higher rate of CIN development after procedure. Interestingly, age, left ventricular ejection fraction, and diabetes mellitus independently predicted CIN. CONCLUSION: Intensive hydration administration appears to be an effective and cost-effective method in CTO-PCI patients, especially in patients without left ventricular function failure. Akadémiai Kiadó 2019-07-02 2019-06 /pmc/articles/PMC7044539/ /pubmed/32148912 http://dx.doi.org/10.1556/1646.11.2019.15 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated.
spellingShingle Original Paper
Aktürk, Erdal
Aşkın, Lütfü
Taşolar, Hakan
Kurtoğlu, Ertuğrul
Türkmen, Serdar
Tanrıverdi, Okan
Uzel, Kader Eliz
Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
title Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
title_full Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
title_fullStr Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
title_full_unstemmed Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
title_short Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
title_sort evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044539/
https://www.ncbi.nlm.nih.gov/pubmed/32148912
http://dx.doi.org/10.1556/1646.11.2019.15
work_keys_str_mv AT akturkerdal evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions
AT askınlutfu evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions
AT tasolarhakan evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions
AT kurtogluertugrul evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions
AT turkmenserdar evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions
AT tanrıverdiokan evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions
AT uzelkadereliz evaluationofcontrastnephropathyinpercutaneoustreatmentofchronictotalocclusions